Pharma and biotech leaders are under increasing pressure to align strategy with execution, elevate decision-making with data and AI, and build resilient, agile portfolios.
The EP3M Summit brings together industry leaders to explore the strategies, technologies, and best practices that shape the future of life sciences innovation portfolio management.
As a Corporate Support Sponsor, Planisware will be onsite to show you how to make smarter portfolio decisions and accelerate innovation while managing risk.
Discover how our solutions can help you:
- Connect strategy to delivery with unified drug development lifecycle management—from discovery through commercialization.
- Harness predictive algorithms, what-if scenarios, Probability of Technical and Regulatory Success (PTRS), and Monte Carlo simulations to make faster, more confident portfolio decisions.
- Simplify regulatory alignment, strengthen forecasting, and adapt your portfolio with greater speed and confidence as priorities and market conditions evolve.
Trusted by 18 of the top 20 global pharmaceutical companies, Planisware’s PPM and SPM solutions help cross-functional teams across R&D, clinical, regulatory, manufacturing, and commercial functions work together to bring life-saving treatments to patients faster.
Meet with our team at EP3M Summit to explore how Planisware can help you optimize your portfolio, reduce risk, and accelerate innovation.